Phase 2 Heart Disease Clinical Trials
17 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–17 of 17 trials
Recruiting
Phase 2
Transition to KPL-387 Monotherapy Dosing & Administration Study
PericarditisHeart DiseasesRecurrent Pericarditis
Kiniksa Pharmaceuticals International, plc80 enrolled12 locationsNCT07288216
Recruiting
Phase 1Phase 2
Influence of Personalized Lung Volume Optimization Maneuver on Lung Function and Cardiac Performance in Children
Mechanical VentilationCongenital Heart DiseaseChildren+8 more
Charite University, Berlin, Germany80 enrolled1 locationNCT07193719
Recruiting
Phase 1Phase 2
A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease
Coronary Heart DiseaseCoronary Artery DiseaseAtheroscleroses
Xia Liang30 enrolled1 locationNCT07493603
Recruiting
Phase 2Phase 3
Sildinafil in Pulmonary Hypertension-Rheumatic Chronic Valvular Disease(RCT)
Pulmonary HypertensionRheumatic Valvular Heart Disease
Sindh Institute of Cardiovascular Diseases100 enrolled1 locationNCT07462260
Recruiting
Phase 2
Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System
Heart FailureCardiomyopathiesCardiogenic Shock+1 more
Stanford University50 enrolled5 locationsNCT06080074
Recruiting
Phase 2
Focused Orticumab Research for Treating Inflammation in Coronary Arteries
Heart DiseaseInflammationCoronary Arterial Disease (CAD)+3 more
Abcentra240 enrolled41 locationsNCT06927739
Recruiting
Phase 1Phase 2
Propranolol Treatment for Postoperative Chylothorax
Congenital Heart DiseasePostoperative Chylothorax
June Wu50 enrolled1 locationNCT06833320
Recruiting
Phase 2
CAMEO-FONTAN -Dapagliflozin in the Failing Fontan Circulation
HFpEF - Heart Failure With Preserved Ejection FractionFontan CirculationSingle Ventricle Heart Disease
Mayo Clinic27 enrolled1 locationNCT06762964
Recruiting
Phase 2
Study of Sivelestat Sodium in OPCABG
Coronary Heart DiseaseCoronary Artery DiseaseCoronary Arterial Disease (CAD)
Affiliated Hospital of Nantong University62 enrolled1 locationNCT07118930
Recruiting
Phase 2Phase 3
Fetal Cerebrovascular Autoregulation in Congenital Heart Disease and Association With Neonatal Neurobehavior
HypoxiaNeurodevelopmental DisordersCongenital Heart Disease in Children+1 more
University of Utah150 enrolled5 locationsNCT05767385
Recruiting
Phase 2
Smart Walk: A Culturally Tailored Smartphone-Delivered Physical Activity Intervention for African American Women
ExerciseDiabetes MellitusPhysical Inactivity+2 more
Arizona State University240 enrolled1 locationNCT06337708
Not Yet Recruiting
Phase 2
Subcutaneous injections of benzathine penicillin G (SCIP) for rheumatic heart disease in Kununurra
Rheumatic heart diseaseRheumatic fever
The Kids Research Institute Australia20 enrolled1 locationACTRN12625000031460
Not Yet Recruiting
Phase 2
Subcutaneous injections of benzathine penicillin G (SCIP) for rheumatic heart disease in Maningrida
Rheumatic heart diseaseRheumatic fever
The Kids Research Institute Australia20 enrolled1 locationACTRN12624001383550
Recruiting
Phase 2
Single or Repeated Intravenous Administration of umbiliCAl Cord Mesenchymal sTrOmal Cells in Ischemic Cardiomyopathy
Ischemic Heart Disease
Roberto Bolli60 enrolled3 locationsNCT06145035
Recruiting
Phase 2
Anti-chlamydophila antibiotic combination therapy in the treatment of patients with Coronary Heart Disease
Coronary Heart DiseaseChlamydophila pneumoniae infection
Centre for Digestive Diseases60 enrolled2 locationsACTRN12618000260224
Not Yet Recruiting
Phase 2
Use of heparin to prevent lung microvascular thrombosis in patients administered aprotinin undergoing cardiac surgery for ischemic heart disease
Ischaemic heart disease
St. Vincents Hospital Melbourne20 enrolled1 locationACTRN12606000328572
Completed
Phase 2
Granulocyte-colony stimulating factor (G-CSF) mobilised autologous endothelial progenitor cells for refractory ischaemic heart disease
Patients with chronic ischaemic heart disease (IHD) on maximal medical therapy, who are not amenable to conventional revascularisation.
The Victor Chang Cardiac Research Institute20 enrolled1 locationACTRN12605000050651